Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges

References

• Lemke JR, Riesch E, Scheurenbrand T, et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012;53:1387-98
   PubMed Web of Science ®Google Scholar
• Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15:733-47
   PubMed Web of Science ®Google Scholar
• Hagemann IS, Cottrell CE, Lockwood CM. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy. Cancer Genet 2013;206:420-31
   PubMed Web of Science ®Google Scholar
• Saunders CJ, Miller NA, Soden SE, et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012;4:154ra135
   PubMed Web of Science ®Google Scholar
• Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 2012;4:162ra154
   PubMed Web of Science ®Google Scholar
• Gilissen C, Hoischen A, Brunner HG, Veltman JA. Disease gene identification strategies for exome sequencing. Eur J Hum Genet 2012;20:490-7
   PubMed Web of Science ®Google Scholar
• Sulonen AM, Ellonen P, Almusa H, et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 2011;12:R94
   Web of Science ®Google Scholar
• Vissers LE, de Ligt J, Gilissen C, et al. A de novo paradigm for mental retardation. Nat Genet 2010;42:1109-12
   PubMed Web of Science ®Google Scholar
• Barbieri CE, Baca SC, Lawrence MS, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012;44:685-9
   PubMed Web of Science ®Google Scholar
• McInerney-Leo AM, Marshall MS, Gardiner B, et al. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas. Clin Endocrinol 2014;80:25-33
   PubMedGoogle Scholar
• Van Allen EM, Wagle N, Stojanov P, et al. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 2014;20:682-8
   PubMed Web of Science ®Google Scholar
• Sikkema-Raddatz B, Johansson LF, de Boer EN, et al. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics. Hum Mutat 2013;34:1035-42
   PubMed Web of Science ®Google Scholar
• Neveling K, Feenstra I, Gilissen C, et al. A post-hoc comparison of the utility of Sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat 2013;34:1721-6
   PubMed Web of Science ®Google Scholar
• Wetterstrand KA. DNA sequencing costs: data from the NHGRI Genome Sequencing Program (GSP). Available from: www.genomturn-around times turn-around times e.gov/sequencingcosts [Last accessed 9 July 2014]
   Google Scholar
• Pfeifer JD. Clinical next generation sequencing in cancer. Cancer Genet 2013;206:409-12
   PubMedGoogle Scholar
• Gallego CJ, Bennette CS, Heagerty P, et al. Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes. Contemp Clin Trials 2014; pii S1551-7144
   Google Scholar
• Mamanova L, Coffey AJ, Scott CE, et al. Target-enrichment strategies for next-generation sequencing. Nat Methods 2010;7:111-1118
   PubMed Web of Science ®Google Scholar
• Rossetti S, Hopp K, Sikkink RA, et al. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol 2012;23:915-33
   PubMed Web of Science ®Google Scholar
• Altmüller J, Budde BS, Nürnberg P. Enrichment of target sequences for next-generation sequencing applications in research and diagnostics. Biol Chem 2014;395:231-7
   PubMedGoogle Scholar
• Desai AN, Jere A. Next-generation sequencing: ready for the clinics? Clin Genet 2012;81:503-10
   PubMed Web of Science ®Google Scholar
• Meynert AM, Bicknell LS, Hurles ME, et al. Quantifying single nucleotide variant detection sensitivity in exome sequencing. BMC Bioinformatics 2013;14:195
   PubMed Web of Science ®Google Scholar
• Weiss MM, Van der Zwaag B, Jongbloed JD, et al. Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories. Hum Mutat 2013;34:1313-21
   PubMed Web of Science ®Google Scholar
• Feliubadalo L, Lopez-Doriga A, Castellsague E, et al. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. Eur J Hum Genet 2013;21:864-70
   PubMed Web of Science ®Google Scholar
• Pugh TJ, Kelly MA, Gowrisankar S, et al. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med 2014;10.1038/gim.2013.204
   PubMedGoogle Scholar
• Gowrisankar S, Lerner-Ellis JP, Cox S, et al. Evaluation of second-generation sequencing of 19 dilated cardiomyopathy genes for clinical applications. J Mol Diagn 2010;12:818-27
   PubMed Web of Science ®Google Scholar
• Sivakumaran TA, Husami A, Kissell D, et al. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss. Otolaryngol Head Neck Surg 2013;148:1007-16
   PubMedGoogle Scholar
• Chan M, Ji SM, Yeo ZX, et al. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn 2012;14:602-12
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Smith C, Salipante SJ, et al. ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 2012;14:357-66
   PubMed Web of Science ®Google Scholar
• Voelkerding KV, Dames S, Durtschi JD. Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2010;12:539-51
   PubMed Web of Science ®Google Scholar
• Coonrod EM, Margraf L, Voelkerding KV. Translating exome sequencing from research to clinical diagnostics. Clin Chem Med 2012;50:1161-8
   Google Scholar
• Patel A, Schwab R, Liu YT, Bafna V. Amplification and thrifty single-molecule sequencing of recurrent somatic structural variations. Genome Res 2014;24:318-28
   PubMed Web of Science ®Google Scholar
• Zhang W, Cui H, Wong LJ. Application of next generation sequencing to molecular diagnosis of inherited diseases. Top Curr Chem 2014;336:19-45
   PubMedGoogle Scholar
• Gargis AS, Kalman L, Berry MW, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 2012;30:1033-6
   PubMed Web of Science ®Google Scholar
• Ellard S, Patrinos GP, Oetting WS. Clinical applications of next-generation sequencing: the 2013 human genome variation society scientific meeting. Hum Mutat 2013;34:1583-7
   PubMed Web of Science ®Google Scholar
• Trujillano D, Ramos MD, González J, et al. Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR. J Med Genet 2013;50:455-62
   PubMed Web of Science ®Google Scholar
• Trujillano D, Perez B, González J, et al. Accurate molecular diagnosis of phenylketonuria and tetrahydrobiopterin-deficient hyperphenylalaninemias using high-throughput targeted sequencing. Eur J Hum Genet 2014;22:528-34
   PubMedGoogle Scholar
• Love MI, Myšičková A, Sun R, et al. Modeling read counts for CNV detection in exome sequencing data. Stat Appl Genet Mol Biol 2011;10
   PubMedGoogle Scholar
• Glöckle N, Kohl S, Mohr J, et al. Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies. Eur J Hum Genet 2014;22:99-104
   PubMed Web of Science ®Google Scholar
• Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 2013;369:1502-11
   PubMed Web of Science ®Google Scholar
• Hennekam RC, Biesecker LG. Next-generation sequencing demands next-generation phenotyping. Hum Mutat 2012;33:884-6
   PubMed Web of Science ®Google Scholar
• Bowdin S, Ray PN, Cohn RD, Meyn MS. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care. Hum Mutat 2014;35:513-19
   PubMedGoogle Scholar
• Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;5:565-74
   Google Scholar
• Christenhusz GM, Devriendt K, Dierickx K. Disclosing incidental findings in genetics contexts: a review of the empirical ethical research. Eur J Med Genet 2013;56:529-40
   PubMed Web of Science ®Google Scholar
• Pyeritz RE. The coming explosion in genetic testing–is there a duty to recontact? N Engl J Med 2011;365:1367-9
   PubMed Web of Science ®Google Scholar
• Letendre. M, Godard B. Expanding the physician’s duty of care: a duty to recontact? Med Law 2004;23:531-9
   PubMedGoogle Scholar
• Hunter AGW, Sharpe N, Mullen M, Meschino WS. Ethical, legal, and practical concerns about recontacting patients to inform them of new information: the case in medical genetics. Am J Med Genet 2001;103:265-76
   PubMed Web of Science ®Google Scholar
• Li X, Buckton AJ, Wilkinson SL, et al. Towards clinical molecular diagnosis of inherited cardiac conditions: a comparison of bench-top genome DNA sequencers. PLoS One 2013;8:e67744
   PubMed Web of Science ®Google Scholar
• Myers FB, Henrikson RH, Bone J, Lee LP. A handheld point-of-care genomic diagnostic system. PLoS One 2013;8:e70266
   PubMed Web of Science ®Google Scholar
• Kircher M, Witten DM, Jain P, et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 2014;46
   PubMedGoogle Scholar
• Flanagan SE, Xie W, Caswell R, et al. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation. Am J Hum Genet 2013;92:131-6
   PubMed Web of Science ®Google Scholar
• Cavalieri S, Pozzi E, Gatti RA, Brusco A. Deep-intronic ATM mutation detected by genomic resequencing and corrected in vitro by antisense morpholino oligonucleotide (AMO). Eur J Hum Genet 2013;21:774-8
   PubMed Web of Science ®Google Scholar
• Westra HJ, Peters MJ, Esko T, et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 2013;45:1238-43
   PubMed Web of Science ®Google Scholar
• Fratkin E, Bercovici S, Stephan DA. The implications of ENCODE for diagnostics. Nat Biotechnol 2012;30:1064-5
   PubMedGoogle Scholar